Kinesin Spindle Protein (KSP or Eg5) - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Kinesin Spindle Protein (KSP or Eg5) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Kinesin Spindle Protein (KSP or Eg5), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kinesin Spindle Protein (KSP or Eg5) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Kinesin Spindle Protein (KSP or Eg5) Overview
  3. Therapeutics Development
  4. Pipeline Products for Kinesin Spindle Protein (KSP or Eg5) - Overview
  5. Pipeline Products for Kinesin Spindle Protein (KSP or Eg5) - Comparative Analysis
  6. Kinesin Spindle Protein (KSP or Eg5) - Therapeutics under Development by Companies
  7. Kinesin Spindle Protein (KSP or Eg5) - Therapeutics under Investigation by Universities/Institutes
  8. Kinesin Spindle Protein (KSP or Eg5) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Kinesin Spindle Protein (KSP or Eg5) - Products under Development by Companies
  13. Kinesin Spindle Protein (KSP or Eg5) - Products under Investigation by Universities/Institutes
  14. Kinesin Spindle Protein (KSP or Eg5) - Companies Involved in Therapeutics Development
  • 4SC AG
  • Alnylam Pharmaceuticals, Inc.
  • Array BioPharma Inc.
  • BIND Therapeutics, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • OncoTherapy Science, Inc.

For more information visit http://www.researchandmarkets.com/research/97j64g/kinesin_spindle

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716